Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced the closing of the previously announced underwritten secondary offering of 51,750,000 shares of the Company's common stock held by certain of its stockholders at the public offering price of $16.25 per share, including the full exercise by the underwriters of their option to purchase up to 6,750,000 additional shares of common stock.

No shares were sold by the Company. The Selling Stockholders received all of the proceeds from this offering.

Goldman Sachs & Co. LLC and J.P. Morgan served as the joint book-running managers and as representatives of the underwriters for the offering. Guggenheim Securities and Jefferies served as co-managers for the offering.

About Avantor 

Avantor® is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. We operate in more than 30 countries and deliver an extensive portfolio of products and services. We set science in motion to create a better world.